$44.39
0.250.57%
Last update: Oct 16, 6:42 PM
$44.20
0.060.14%
Boston Scientific Corp
BSXNYSE
Boston Scientific (BSX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Boston Scientific (BSX) last issued guidance on July 29, 2026 for Q3 2026. The company guided earnings per share in the range of $0.8 - $0.82, compared to a consensus EPS estimate of $0.84. Boston Scientific also guided revenue in the range of $5.22B - $5.32B for the period.
Compared to prior guidance, Boston Scientific lowered its revenue forecast from a prior range of $21.18B - $21.38B.
Boston Scientific has issued 35 guidance updates between October 26, 2022 and July 29, 2026. During this period, the company raised its outlook 13 times and lowered it 18 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.83 | $0.79 | $0.78 | $0.71 |
| Actual | $0.86 | $0.80 | $0.80 | $0.75 |
| Surprise | +3.61% | +1.27% | +2.56% | +5.63% |
| Revenue | ||||
| Estimate | $5.38B | $5.18B | $5.28B | $4.97B |
| Actual | $5.44B | $5.20B | $5.29B | $5.07B |
| Surprise | +1.22% | +0.45% | +0.18% | +1.86% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.75 | $0.83 | $0.81 | $0.86 |
| Revenue | ||||
| Consensus | $5.11B | $5.40B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $0.86 | $0.83 | 3.61 % |
| Q1 | Apr 22, 2026 | $0.80 | $0.79 | 1.27 % |
| Q4 | Feb 4, 2026 | $0.80 | $0.78 | 2.56 % |
| Q3 | Oct 22, 2025 | $0.75 | $0.71 | 5.63 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $5.44B | $5.38B | 1.22 % |
| Q1 | Apr 22, 2026 | $5.20B | $5.18B | 0.45 % |
| Q4 | Feb 4, 2026 | $5.29B | $5.28B | 0.18 % |
| Q3 | Oct 22, 2025 | $5.07B | $4.97B | 1.86 % |
